RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)
- Status
- SUSPENDED
- Phase
- PHASE3
Clinical Trials Related to REGENXBIO Inc.
Related studies linked through entity extraction aliases.
Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)
- Status
- RECRUITING
- Phase
- PHASE2
Long Term Follow-up for RGX-202
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Long Term Follow-Up for RGX-111
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD
- Status
- RECRUITING
- Phase
- N/A
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- Status
- RECRUITING
- Phase
- PHASE3
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Long-term Follow-Up for RGX-121
- Status
- UNKNOWN
- Phase
- N/A
Mucopolysaccharidosis Type II Observational
- Status
- WITHDRAWN
- Phase
- N/A
RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Retrospective, Natural History Study in Children With CLN2
- Status
- WITHDRAWN
- Phase
- N/A
An Observational Study in Children With CLN2 Batten Disease
- Status
- WITHDRAWN
- Phase
- N/A
Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients
- Status
- COMPLETED
- Phase
- N/A
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501
- Status
- UNKNOWN
- Phase
- N/A
RGX-111 Gene Therapy in Patients With MPS I
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Mucopolysaccharidosis Type II Natural History
- Status
- COMPLETED
- Phase
- N/A